7 completed, 2 terminated, 1 withdrawn. 7 Phase 2, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Terminated 1 |
| Phase 1 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
Follow P276-00: new trials by email Literature Review of P276-00 trials Research Report on P276-00
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 P276-00, Radiation Therapy, Cisplatin - Radiation Induced Mucositis in Head and Neck Cancer | Phase 2 | Completed | Piramal Enterprises Limited | 73 | 2012-07-01 | 2014-09-04 |
| A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma P276-00 - Mantle Cell Lymphoma | Phase 2 | Terminated | Piramal Enterprises Limited | 13 | 2009-11-01 | 2012-07-27 |
| Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer P276-00, External beam radiotherapy (EBRT) - Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | Completed | Piramal Enterprises Limited | 23 | 2009-08-01 | 2012-11-22 |
| Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer P276-00, Gemcitabine - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Piramal Enterprises Limited | 23 | 2009-05-01 | 2012-01-20 |
| Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression P276-00 - Melanoma | Phase 2 | Completed | Piramal Enterprises Limited | 12 | 2009-05-01 | 2012-12-04 |
| Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma P276-00 - Multiple Myeloma | Phase 1 | Withdrawn | Piramal Enterprises Limited | 35 | 2008-12-01 | 2009-04-23 |
| A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer P276-00 - Squamous Cell Carcinoma of Head and Neck | Phase 2 | Completed | Piramal Enterprises Limited | 86 | 2008-09-01 | 2013-07-10 |
| Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma P276-00 - Relapsed and/or Refractory Multiple Myeloma | Phase 1 / Phase 2 | Completed | Piramal Enterprises Limited | 19 | 2008-01-01 | 2012-11-21 |
| Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms P276-00 - Neoplasm | Phase 1 | Terminated | Piramal Enterprises Limited | 28 | 2006-03-01 | 2009-01-01 |
| Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms P276-00 - Neoplasm | Phase 1 | Completed | Piramal Enterprises Limited | 50 | 2005-05-01 | 2009-01-01 |
Multiple Myeloma (2) · Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Head and Neck Neoplasms (1) · Lymphoma, Mantle-Cell (1) · Melanoma (1) · Pancreatic Neoplasms (1)
Piramal Enterprises Limited (10)
India (9) · Australia (1) · Canada (1) · New Zealand (1) · United States (1)
Raghunadharao D, MD, DM (2) · Raj Nagarkar, MS (2) · Ajay Gopal, MD (1) · Ajay Mehta, MS (1) · Amol Bapaye, MS (1) · Anand Pathak, MD (1) · Andre Goy, MD (1) · Anita Ramesh, MD (1) · Balaji Shewalkar, MD, DNB (1) · Brad Kahl, MD (1) · Cecil Ross, MD (1) · Craig Reeder, MD (1) · Dr. Ajay Mehta (1) · Dr. Chetan Deshmukh, MD, DM (1) · Dr. Lalit Mohan Sharma (1)